EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Evaluation of renal markers in systemic autoimmune diseases

Hari Krishnamurthy iD, Yuanyuan Yang, Qi Song, Karthik Krishna, Vasanth Jayaraman, Tianhao Wang, Kang Bei, John J Rajasekaran

PLOS ONE · 2023

DOI: 10.1371/journal.pone.0278441 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Hari Krishnamurthy und 7 weiteren Autor:innen. Beteiligte Einrichtung: Vibrant America LLC., San Carlos, CA, United States of America. Hauptthemen laut MEDLINE: Lupus Erythematosus, Systemic, Autoimmune Diseases, Connective Tissue Diseases, Arthritis, Rheumatoid. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Vibrant America LLC.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Renal involvement is a common occurrence in subjects with systemic autoimmune diseases. The renal manifestation and its severity depend on the underlying condition and may reversely complicate the clinical course of autoimmune diseases. Renal function markers have been widely used in the assessment of normal functioning of kidneys including glomerular filtration rate and concentrating and diluting capacity of the kidney. An increase or decrease in the values of these markers may indicate kidney dysfunction. In this study, a number of critical renal markers were examined in seropositive autoimmune diseases including systemic lupus erythematosus (SLE), connective tissue disorder (CTD), and rheumatoid arthritis (RA). The data from three cohorts of subjects enrolled in renal markers and autoimmune antibody testing between January 2015 to August 2019 were retrospectively studied. The prevalence of renal markers that were out of the reference range and their average levels in female and male subgroups across SLE, CTD, and RA cohorts were compared and analyzed. The levels of renal markers are significantly affected by the presence of autoantibodies, in particular eGFR, cystatin C, and albumin. Autoantibodies were also more frequent in subjects with severe renal function damage. Close follow-up of both renal markers and autoantibodies may potentially assist in the early diagnosis of kidney diseases and improve the survival and life expectancy of autoimmune patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lupus Erythematosus, SystemicAutoimmune DiseasesConnective Tissue DiseasesArthritis, RheumatoidHumansMaleFemaleRetrospective StudiesKidneyAutoantibodies

Substanzen

Autoantibodies

Autor:innen und Institutionen

  • Vibrant America LLC., San Carlos, CA, United States of America.

ORCID-Profile: Hari Krishnamurthy

Förderung

  • Vibrant America LLC

Zitieren

APA

Krishnamurthy, H., Yang, Y., Song, Q., Krishna, K., Jayaraman, V., Wang, T., Bei, K., & Rajasekaran, J. J. (2023). Evaluation of renal markers in systemic autoimmune diseases. PLOS ONE. https://doi.org/10.1371/journal.pone.0278441

Vancouver

Krishnamurthy H, Yang Y, Song Q, Krishna K, Jayaraman V, Wang T, et al. Evaluation of renal markers in systemic autoimmune diseases. PLOS ONE. 2023. doi:10.1371/journal.pone.0278441

BibTeX
@article{Krishnamurthy2023,
  author = {Krishnamurthy, Hari and Yang, Yuanyuan and Song, Qi and Krishna, Karthik and Jayaraman, Vasanth and Wang, Tianhao and Bei, Kang and Rajasekaran, John J},
  title = {Evaluation of renal markers in systemic autoimmune diseases},
  journal = {PLOS ONE},
  year = {2023},
  doi = {10.1371/journal.pone.0278441}
}
Kostenlos starten →